scispace - formally typeset
G

Garry P. Nolan

Researcher at Stanford University

Publications -  519
Citations -  54521

Garry P. Nolan is an academic researcher from Stanford University. The author has contributed to research in topics: Immune system & T cell. The author has an hindex of 104, co-authored 474 publications receiving 46025 citations. Previous affiliations of Garry P. Nolan include Massachusetts Institute of Technology & New York University.

Papers
More filters
Journal ArticleDOI

The Human Cell Atlas

Aviv Regev, +81 more
- 05 Dec 2017 - 
TL;DR: An open comprehensive reference map of the molecular state of cells in healthy human tissues would propel the systematic study of physiological states, developmental trajectories, regulatory circuitry and interactions of cells, and also provide a framework for understanding cellular dysregulation in human disease.
Journal ArticleDOI

Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE

TL;DR: This work presents a versatile computational approach, spanning-tree progression analysis of density-normalized events (SPADE), which facilitates the analysis of cellular heterogeneity, the identification of cell types and comparison of functional markers in response to perturbations.
Journal ArticleDOI

Mass Cytometry: Single Cells, Many Features.

TL;DR: The current state of mass cytometry is reviewed, providing an overview of the instrumentation, its present capabilities, and methods of data analysis, as well as thoughts on future developments and applications.
Journal ArticleDOI

Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development

TL;DR: This study provides a comprehensive analysis of human B lymphopoiesis, laying a foundation to apply this approach to other tissues and "corrupted" developmental processes including cancer.
Journal ArticleDOI

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.

TL;DR: The nuclear replication and retention functions of the Epstein-Barr virus have been utilized here to maintain Retroviral constructs episomally within human cell-based retroviral packaging lines, affording reproducibly rapid, large-scale, stable, and high-titer retrovirus production.